Interactions of omeprazole and precursors with β-cyclodextrin host molecules

被引:15
作者
Braga, SS
Ribeiro-Claro, P
Pillinger, M
Gonçalves, IS
Fernandes, AC
Pereira, F
Romao, CC
Correia, PB
Teixeira-Dias, JJC
机构
[1] Univ Aveiro, Dept Chem, CICECO, P-3810193 Aveiro, Portugal
[2] Inst Tecnol Quim & Biol, EAN, P-2781901 Oeiras, Portugal
[3] Herbex Chem Prod Ltd, P-2710 Sintra, Portugal
关键词
ab initio calculations; CP MAS NMR; cyclodextrins; inclusion complexation; omeprazole;
D O I
10.1023/B:JIPH.0000003924.14479.9c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
beta-Cyclodextrin (beta-CD) was mixed with omeprazole and some of its precursors in aqueous or water/ethanol solutions, and the resulting crystalline products have been characterized by elemental analysis, thermogravimetry, powder X-ray diffraction (XRD), FTIR and C-13 CP MAS NMR spectroscopy. In the case of 2-chloromethyl-4-methoxy-3,5-dimethylpyridine.HCl, it was found that the solid product always consisted of pure beta-CD hydrate. On the other hand, a 2 : 1 (host-to-guest) inclusion complex was obtained between beta-CD and 2-methoxy-2-mercaptobenzimidazole. The thioether intermediate 5-methoxy-2-[(3,5-dimethyl-4-methoxy-2-pyridine)methylthio]-1H-benzimidazole and its sulfoxide derivative (omeprazole) both formed 1:1 inclusion complexes with beta-CD. Powder XRD indicates that the crystal packing of beta-CD host molecules is herringbone-type for the 2:1 complex, and channel-type for the 1:1 complexes. Ab initio calculations were carried out to investigate the host-guest interactions. It was found that the interaction with the pyridine fragment is wholly repulsive, due to the presence of several ring substituents. On the other hand, the inclusion of the benzimidazole fragment is energetically favored, but highly dependent on the orientation of the substituent methoxy group.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 35 条
[1]   Study of omeprazole-γ-cyclodextrin complexation in the solid state [J].
Arias, MJ ;
Moyano, JR ;
Muñoz, P ;
Ginés, JM ;
Justo, A ;
Giordano, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (03) :253-259
[2]   Encapsulation of cyano(cyclopentadienyl) complexes of iron with β-cyclodextrin [J].
Braga, SS ;
Gonçalves, IS ;
Ribeiro-Claro, P ;
Lopes, AD ;
Pillinger, M ;
Teixeira-Dias, JJC ;
Rocha, J ;
Romao, CC .
SUPRAMOLECULAR CHEMISTRY, 2002, 14 (04) :359-366
[3]   Solid state inclusion compound of S-ibuprofen in β-cyclodextrin:: structure and characterisation [J].
Braga, SS ;
Gonçalves, IS ;
Herdtweck, E ;
Teixeira-Dias, JJC .
NEW JOURNAL OF CHEMISTRY, 2003, 27 (03) :597-601
[4]  
BRANDSTROM AE, 1985, Patent No. 4544750
[5]  
FERNANDES AC, 1999, Patent No. 102317A
[6]  
FERNANDES AC, 2000, Patent No. 001057
[7]  
FERNANDES AC, 1999, Patent No. 102631E
[8]  
FERNANDES AC, 1998, Patent No. 102114N
[9]  
FERNANDES AC, 1998, Patent No. 102116R
[10]  
Frisch M.J., 2016, Gaussian 16 Revision C. 01. 2016, V16, P01